Blockade of Transient Receptor Potential Vanilloid 4 Enhances Antioxidation after Myocardial Ischemia/Reperfusion. 2019

Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Antioxidative stress provides a cardioprotective effect during myocardial ischemia/reperfusion (I/R). Previous research has demonstrated that the blockade of transient receptor potential vanilloid 4 (TRPV4) attenuates myocardial I/R injury. However, the underlying mechanism remains unclear. The current study is aimed at investigating the antioxidative activity of TRPV4 inhibition and elucidating the underlying mechanisms in vitro and ex vivo. We found that the inhibiting TRPV4 by the selective TRPV4 blocker HC-067047 or specific TRPV4-siRNA significantly reduces reactive oxygen species (ROS) and methane dicarboxylic aldehyde (MDA) levels in H9C2 cells exposed to hypoxia/reoxygenation (H/R). Meanwhile, the activity of antioxidative enzymes, particularly superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), is enhanced. Furthermore, after H/R, HC-067047 treatment increases the expression of P-Akt and the translocation of nuclear factor E2-related factor 2 (Nrf2) and related antioxidant response element (ARE) mainly including SOD, GSH-Px, and catalase (CAT). LY294002, an Akt inhibitor, suppresses HC-067047 and specific TRPV4-siRNA-induced Nrf2 expression and its nuclear accumulation. Nrf2 siRNA attenuates HC-067047 and specific TRPV4-siRNA-induced ARE expression. In addition, treatment with LY294002 or Nrf2 siRNA significantly attenuates the antioxidant and anti-injury effects of HC-067047 in vitro. Finally, in experiments on isolated rat hearts, we confirmed the antioxidative stress roles of TRPV4 inhibition during myocardial I/R and the application of exogenous H2O2. In conclusion, the inhibition of TRPV4 exerts cardioprotective effects through enhancing antioxidative enzyme activity and expressions via the Akt/Nrf2/ARE pathway.

UI MeSH Term Description Entries
D008297 Male Males
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
February 2017, Scientific reports,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
April 2022, The Annals of thoracic surgery,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
January 2019, Frontiers in pharmacology,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
December 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
September 2016, Journal of the American Heart Association,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
March 2018, Scientific reports,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
April 2024, The Journal of thoracic and cardiovascular surgery,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
May 2021, European journal of pharmacology,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
March 2022, Cardiovascular research,
Qiongfeng Wu, and Kai Lu, and Zhaoyang Zhao, and Binbin Wang, and Huixia Liu, and Shaoshao Zhang, and Jie Liao, and Yu Zeng, and Qian Dong, and Ning Zhao, and Bing Han, and Yimei Du
April 2018, Neuropathology : official journal of the Japanese Society of Neuropathology,
Copied contents to your clipboard!